Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A SARS-CoV-2 Infection Model in Mice Demonstrates Protection by Neutralizing Antibodies
Ahmed O. Hassan, James Brett Case, Emma S. Winkler, et al.
Cell (2020) Vol. 182, Iss. 3, pp. 744-753.e4
Open Access | Times Cited: 538

Showing 76-100 of 538 citing articles:

Animal Models for COVID-19: Hamsters, Mouse, Ferret, Mink, Tree Shrew, and Non-human Primates
Shuyu Shou, Menghui Liu, Yang Yang, et al.
Frontiers in Microbiology (2021) Vol. 12
Open Access | Times Cited: 108
Two Years into the COVID-19 Pandemic: Lessons Learned
Severino Jefferson Ribeiro da Silva, Jéssica Catarine Frutuoso do Nascimento, Renata Pessôa Germano Mendes, et al.
ACS Infectious Diseases (2022) Vol. 8, Iss. 9, pp. 1758-1814
Open Access | Times Cited: 103
Multivalent designed proteins neutralize SARS-CoV-2 variants of concern and confer protection against infection in mice
Andrew C. Hunt, James Brett Case, Young‐Jun Park, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 646
Open Access | Times Cited: 97
SARS-CoV-2 infection produces chronic pulmonary epithelial and immune cell dysfunction with fibrosis in mice
Kenneth H. Dinnon, Sarah R. Leist, Kenichi Okuda, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 664
Open Access | Times Cited: 92
Animal models in SARS-CoV-2 research
Hin Chu, Jasper Fuk‐Woo Chan, Kwok‐Yung Yuen
Nature Methods (2022) Vol. 19, Iss. 4, pp. 392-394
Open Access | Times Cited: 88
A tandem-repeat dimeric RBD protein-based covid-19 vaccine zf2001 protects mice and nonhuman primates
Yaling An, Shihua Li, Xiyue Jin, et al.
Emerging Microbes & Infections (2022) Vol. 11, Iss. 1, pp. 1058-1071
Open Access | Times Cited: 81
Animal models for COVID-19: advances, gaps and perspectives
Changfa Fan, Yong Wu, Rui Xiong, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 79
An adjuvant strategy enabled by modulation of the physical properties of microbial ligands expands antigen immunogenicity
Francesco Borriello, Valentina Poli, Ellen Shrock, et al.
Cell (2022) Vol. 185, Iss. 4, pp. 614-629.e21
Open Access | Times Cited: 78
Type I interferons and SARS-CoV-2: from cells to organisms
Paul Bastard, Qian Zhang, Shen‐Ying Zhang, et al.
Current Opinion in Immunology (2022) Vol. 74, pp. 172-182
Open Access | Times Cited: 70
Human neutralizing antibodies to cold linear epitopes and subdomain 1 of the SARS-CoV-2 spike glycoprotein
Filippo Bianchini, Virginia Crivelli, Morgan E. Abernathy, et al.
Science Immunology (2023) Vol. 8, Iss. 81
Open Access | Times Cited: 58
COVID-19 therapeutics: Small-molecule drug development targeting SARS-CoV-2 main protease
Thales Kronenberger, Stefan Laufer, Thanigaimalai Pillaiyar
Drug Discovery Today (2023) Vol. 28, Iss. 6, pp. 103579-103579
Open Access | Times Cited: 40
Enhancing antibody responses by multivalent antigen display on thymus-independent DNA origami scaffolds
Eike‐Christian Wamhoff, Larance Ronsard, Jared Feldman, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 40
SARS-CoV-2 immunity in animal models
Chen Zhao, Yaochang Yuan, Qing‐Tao Hu, et al.
Cellular and Molecular Immunology (2024) Vol. 21, Iss. 2, pp. 119-133
Open Access | Times Cited: 14
Diverse Functional Autoantibodies in Patients with COVID-19
Eric Y. Wang, Tianyang Mao, Jon Klein, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 131
Association between SARS-CoV-2 Neutralizing Antibodies and Commercial Serological Assays
Mei San Tang, James Brett Case, Caroline E Franks, et al.
Clinical Chemistry (2020) Vol. 66, Iss. 12, pp. 1538-1547
Open Access | Times Cited: 127
Intranasal vaccination with a lentiviral vector protects against SARS-CoV-2 in preclinical animal models
Min‐Wen Ku, Maryline Bourgine, Pierre Authié, et al.
Cell Host & Microbe (2020) Vol. 29, Iss. 2, pp. 236-249.e6
Open Access | Times Cited: 126
Measuring immunity to SARS-CoV-2 infection: comparing assays and animal models
David S. Khoury, Adam K. Wheatley, Mitchell D. Ramuta, et al.
Nature reviews. Immunology (2020) Vol. 20, Iss. 12, pp. 727-738
Open Access | Times Cited: 122
Humoral immune responses and neutralizing antibodies against SARS-CoV-2; implications in pathogenesis and protective immunity
Jorge Carrillo, Nuria Izquierdo‐Useros, Carlos Ávila‐Nieto, et al.
Biochemical and Biophysical Research Communications (2020) Vol. 538, pp. 187-191
Open Access | Times Cited: 114
SARS-CoV-2 responsive T cell numbers and anti-Spike IgG levels are both associated with protection from COVID-19: A prospective cohort study in keyworkers
David Wyllie, Hayley E. Jones, Ranya Mulchandani, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 106
Inflammation and thrombosis in COVID-19 pathophysiology: proteinase-activated and purinergic receptors as drivers and candidate therapeutic targets
Krishna Sriram, Paul A. Insel
Physiological Reviews (2020) Vol. 101, Iss. 2, pp. 545-567
Open Access | Times Cited: 100
Susceptibility of tree shrew to SARS-CoV-2 infection
Yuan Zhao, Junbin Wang, Dexuan Kuang, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 99
Endothelial cell infection and dysfunction, immune activation in severe COVID-19
Zhongnan Qin, Fengming Liu, Robert V. Blair, et al.
Theranostics (2021) Vol. 11, Iss. 16, pp. 8076-8091
Open Access | Times Cited: 98
A potently neutralizing SARS-CoV-2 antibody inhibits variants of concern by utilizing unique binding residues in a highly conserved epitope
Laura A. VanBlargan, Lucas J. Adams, Zhuoming Liu, et al.
Immunity (2021) Vol. 54, Iss. 10, pp. 2399-2416.e6
Open Access | Times Cited: 94
A humanized mouse model of chronic COVID-19
Esen Sefik, Benjamin Israelow, Haris Mirza, et al.
Nature Biotechnology (2021) Vol. 40, Iss. 6, pp. 906-920
Open Access | Times Cited: 94
Mouse-adapted SARS-CoV-2 replicates efficiently in the upper and lower respiratory tract of BALB/c and C57BL/6J mice
Jinliang Wang, Lei Shuai, Chong Wang, et al.
Protein & Cell (2020) Vol. 11, Iss. 10, pp. 776-782
Open Access | Times Cited: 93

Scroll to top